Cart

Sampling fee?

The sample collection fee is a fixed cost that refers to the visit to the clinic where you submit your sample. The fee is not affected by how many tests you have ordered, but varies depending on the order value:

  • For order values under SEK 350, the sampling fee is SEK 119.
  • For order values between SEK 350 and SEK 1 000, the fee is SEK 49.
Free sampling fee

For purchases over 1 000 SEK, the sampling fee is included.

HPV vaccine – which cancers does it protect against?

HPV vaccine – which cancers does it protect against?

The HPV vaccine is best known for protecting against cervical cancer, but the fact is that it protects against several different types of cancer caused by human papillomavirus (HPV), and there is no other method that is equally effective for prevention.

Quick version

What is HPV?

Human papillomavirus (HPV) is a very common virus that is mainly transmitted through sexual contact. There are over 200 different types of HPV, and most infections clear up on their own. However, some types of the virus, known as high-risk HPV, can cause cellular changes and cancer.

How the HPV vaccine works

The HPV vaccine protects against the virus by stimulating the immune system to produce antibodies against specific types of HPV. The vaccine can prevent new HPV infections, but it cannot treat an ongoing infection or already established cellular changes.

Which cancers does the HPV vaccine protect against?

Cervical cancer

More than 90 percent of all cervical cancers are caused by HPV. The vaccine has shown very positive preventive results against both HPV infection and precancerous changes.

Anal cancer

Anal cancer is also often caused by HPV. Around 90% of cases are related to HPV, primarily HPV type 16. Vaccination reduces the risk in both men and women.

Throat and tonsil cancer (oropharyngeal cancer)

A growing proportion of cancers of the throat and tonsils have been shown to be caused by HPV. In the Western world, up to 60–70 percent of these cancers can be linked to HPV, and men are affected more often than women.

Penile cancer

Approximately 40–50 percent of all cases of penile cancer are caused by HPV, mainly HPV type 16. The disease is rare, but vaccination can help further reduce the risk.

Vulvar and vaginal cancer

HPV causes up to 70 percent of all cancers of the external and internal female genital organs outside the cervix, including the vulva and vagina.

Who should get vaccinated?

Both girls and boys should be vaccinated. The HPV vaccine provides the best protection before sexual debut, but people who have already had sex are also recommended to get vaccinated. Since a person is rarely exposed to all the HPV types covered by the vaccine, vaccination is often still beneficial.

When should you seek medical care?

Be alert to symptoms such as bleeding, persistent sores, lumps, or pain in the genital area, anus, throat, or pharynx. Always participate in the screening programs offered, such as cervical cancer screening. This is an effective way to detect the virus early.

Can HPV be prevented?

Vaccination is the most effective preventive measure. Regular screening and condom use also reduce the risk, but do not provide complete protection against HPV.

Related conditions

HPV can also cause genital warts and cellular changes that do not develop into cancer, but may still require monitoring and treatment.

Questions and answers

The vaccine does not protect against all HPV types. It provides effective protection against the most common HPV types, including the high-risk types HPV 16 and 18. These virus types cause the majority of HPV-related cancers.

Yes, the risk is significantly reduced but not completely eliminated. That’s why it’s important to attend regular check-ups and continue participating in the recommended screening programs.

No, both men and women are at risk of developing HPV-related cancers and are recommended to get vaccinated.

The vaccine cannot cure an ongoing infection, but it can protect against other types of HPV that you have not already been infected with.

Studies show that the vaccine provides protection for at least 10–15 years, and likely longer than that.

Yes. Large studies have been conducted and the vaccine is used worldwide. Most side effects are mild, such as local soreness at the injection site.

Yes, it is important to continue participating in cervical cancer screening because the vaccine does not provide 100 percent protection.